Monday - December 23, 2024

N-Alkylaryl-5-Oxyaryl-Octahydro-Cyclopenta[C]pyrrole Negative Allosteric Modulators of NR2B

2024-11-19

ALEXANDRIA, Virginia, Nov. 19 -- NOVARTIS AG, Basel, Switzerland has been assigned a patent (No. US 12145909 B2, initially filed May 3, 2022) developed by three inventors David R. Anderson, Salem, Connecticut; Robert A. Volkmann, Mystic, Connecticut; and Frank S. Menniti, Mystic, Connecticut, for "N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

N-Alkylaryl-5-Oxyaryl-Octahydro-Cyclopenta[C]pyrrole Negative Allosteric Modulators of NR2B

Information Request Form

Copyright Targeted News Service 2024